PMDA drug package insert
メトピロンカプセル250mg
PMDA Prescription drug · セオリア ファーマ株式会社 · package insert Sep 1, 2026
Key facts
| Brand names | メトピロンカプセル250mg |
|---|---|
| Nonproprietary names | メチラポン |
| Companies | 製造販売元／セオリア ファーマ株式会社, 販売／武田薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 下垂体ACTH分泌機能検査用薬 副腎皮質ホルモン合成阻害剤 |
| Therapeutic category codes | 8772231, 872499 |
| YJ codes | 7223001M1035 |
| Approval numbers | 21900AMX00702 |
| Package insert edition | 第3版 |
| Package insert date | Sep 1, 2026 |
| PMDA document key | 380999_7223001M1035_2 |
| PMDA company code | 380999 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: